Think of Ajovy as Similar to Aimovig and Emgality for Migraine Prophylaxis

November 2020

You'll see Ajovy (fremanezumab), a new injectable to PREVENT migraine in adults.

Think of it as similar to Aimovig (erenumab) and Emgality (galcanezumab). They decrease the number of migraines by blocking calcitonin gene-related peptide (CGRP).

They'll be saved for when patients can't tolerate, or don't respond to, oral meds for preventing migraine...such as propranolol or topiramate.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Errors Prevent Mix-Ups With Meds That Require Reconstitution
Fever Improve Accuracy With Noncontact Infrared Thermometers
Allergic Reactions Know Differences Between Emerade and Other Epinephrine Injectors
Substance Use Disorder Stay Alert for Surprising Rxs and OTCs Being Abused
Supplements Listen for Patients Asking About "Memory Supplements"
Med Safety Don't Be Afraid to Speak Up for Safety
Med Administration Help Investigate Whether a Med Can Be Cut or Crushed
Migraine Think of Ajovy as Similar to Aimovig and Emgality for Migraine Prophylaxis
HIV & AIDS Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva

Think of Ajovy as Similar to Aimovig and Emgality for Migraine Prophylaxis

Practical advice for a better career, with unlimited access to CE

Table of Contents